Paper32621804
Ubiquitination of disease-causing CFTR variants in a microsome-based assay.
Estabrooks SK and 1 other. Anal Biochem, 2020. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Ubiquitination of disease-causing CFTR variants in a microsome-based assay. Papers, record 32621804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32621804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Assay | Major topic |
| Cystic Fibrosis | Major topic |
| Cystic Fibrosis Transmembrane Conductance Regulator | Major topic |
| Endoplasmic Reticulum | |
| HEK293 Cells | |
| Humans | |
| Microsomes | |
| Proteolysis | |
| Ubiquitination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R35 GM131732 | NIGMS NIH HHS | United States | R35GM131732 | PubMed and NIH |
Source NIH RePORTER
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22281052 | Orientational preferences of neighboring helices can drive ER insertion of a marginally hydrophobic transmembrane helix. | Mol Cell | 2012 | https://conductscience.org/library/papers/22281052 | PubMed |
| 2 | 26183966 | Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation. | Sci Rep | 2015 | https://conductscience.org/library/papers/26183966 | PubMed |
| 3 | 19176754 | Cooperative assembly and misfolding of CFTR domains in vivo. | Mol Biol Cell | 2009 | https://conductscience.org/library/papers/19176754 | PubMed |
| 4 | 25577540 | A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface. | Mol Biotechnol | 2015 | https://conductscience.org/library/papers/25577540 | PubMed |
| 5 | 9351815 | Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. | EMBO J | 1997 | https://conductscience.org/library/papers/9351815 | PubMed |
| 6 | 31936842 | Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31936842 | PubMed |
| 7 | 7529176 | Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. | EMBO J | 1994 | https://conductscience.org/library/papers/7529176 | PubMed |
| 8 | 16469739 | Cysteine string protein monitors late steps in cystic fibrosis transmembrane conductance regulator biogenesis. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16469739 | PubMed |
| 9 | 12069690 | The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. | Biochem J | 2002 | https://conductscience.org/library/papers/12069690 | PubMed |
| 10 | 16127463 | Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16127463 | PubMed |
| 11 | 15176679 | Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. | Eur Respir J | 2004 | https://conductscience.org/library/papers/15176679 | PubMed |
| 12 | 17632520 | A novel tripartite motif involved in aquaporin topogenesis, monomer folding and tetramerization. | Nat Struct Mol Biol | 2007 | https://conductscience.org/library/papers/17632520 | PubMed |
| 13 | 8798455 | Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8798455 | PubMed |
| 14 | 7553864 | Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. | Cell | 1995 | https://conductscience.org/library/papers/7553864 | PubMed |
| 15 | 20595578 | Peripheral protein quality control removes unfolded CFTR from the plasma membrane. | Science | 2010 | https://conductscience.org/library/papers/20595578 | PubMed |
| 16 | 31776420 | Nanomolar-potency 'co-potentiator' therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants. | Sci Rep | 2019 | https://conductscience.org/library/papers/31776420 | PubMed |
| 17 | 20110346 | The endoplasmic reticulum-associated degradation of the epithelial sodium channel requires a unique complement of molecular chaperones. | Mol Biol Cell | 2010 | https://conductscience.org/library/papers/20110346 | PubMed |
| 18 | 15342786 | Distinct roles for the Hsp40 and Hsp90 molecular chaperones during cystic fibrosis transmembrane conductance regulator degradation in yeast. | Mol Biol Cell | 2004 | https://conductscience.org/library/papers/15342786 | PubMed |
| 19 | 29809151 | The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins. | Elife | 2018 | https://conductscience.org/library/papers/29809151 | PubMed |
| 20 | 11146634 | The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11146634 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41459335 | Reconstitution of CFTR ubiquitination identifies lysine-420 as a regulator of cell surface residence and current. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/41459335 | PubMed |
| 38698045 | COPII cage assembly factor Sec13 integrates information flow regulating endomembrane function in response to human variation. | Sci Rep | 2024 | https://conductscience.org/library/papers/38698045 | PubMed |
| 38057493 | The generation of detergent-insoluble clipped fragments from an ERAD substrate in mammalian cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/38057493 | PubMed |
| 34246753 | Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination. | Bioorg Med Chem Lett | 2021 | https://conductscience.org/library/papers/34246753 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32621804
GET https://conductscience.org/api/papers/v1/32621804/references?page=2